Paul D. Arata
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Paul D. Arata
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.
20
| Holding Company | Medical Specialties | 20 |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD
8
| Extinct | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul D. Arata
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member Director/Board Member Corporate Officer/Principal Investor Relations Contact General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Celera Diagnostics LLC
 Celera Diagnostics LLC Medical/Nursing ServicesHealth Services Celera Diagnostics LLC discovers, develops and commercializes molecular diagnostics. The firm enables physicians to diagnose, monitor and treat disease. It manufactures products for infectious disease testing and for genetic conditions such as cystic fibrosis. The company was founded in 2001 by Kathy Ordoñez and is headquartered in Alameda, CA. | Medical/Nursing Services | Corporate Officer/Principal Public Communications Contact Chief Tech/Sci/R&D Officer | |
| AFFYMETRIX, INC. | Medical Specialties | Sales & Marketing Chief Operating Officer | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Sales & Marketing Corporate Officer/Principal | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| University of Connecticut | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| Washington State University | College/University | Doctorate Degree | |
Atelerix Life Sciences, Inc.
 Atelerix Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Atelerix Life Sciences, Inc. is a pharmaceutical company that is developing a new drug, ATLX-0199, to address the unmet need of opioid-induced respiratory depression (OIRD) in surgical patients. The company is based in Charlottesville, VA. Atelerix Life Sciences was founded by David G. Kalergis, Benjamin Gaston, James Bates, and Stephen Lewis, with David G. Kalergis serving as the CEO since incorporation. The current drug for OIRD, Naloxone, is problematic and used infrequently because it reverses pain relief. ATLX-0199 safely stimulates opioid-depressed respiratory drive without interfering with opioid-induced analgesia. | Pharmaceuticals: Major | Director/Board Member | |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Solu Therapeutics
 Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Pharmaceuticals: Major | Director/Board Member | |
| ASPIRA WOMEN'S HEALTH INC. | Biotechnology | Sales & Marketing | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Northern Illinois University | College/University | Undergraduate Degree | |
Aduro Biotech Holdings Europe BV
 Aduro Biotech Holdings Europe BV BiotechnologyHealth Technology Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands. | Biotechnology | Corporate Officer/Principal | |
DNAnexus, Inc.
 DNAnexus, Inc. Packaged SoftwareTechnology Services DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA. | Packaged Software | Corporate Officer/Principal | |
| Sidney Kimmel Medical College | College/University | Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Covington & Burling LLP
 Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Covington & Burling LLP provides legal services. It also provides support services in the following administrative departments including accounting, human resources, information research services, information technology services, library, operations, marketing, practice systems support, recruitment, attorney and alumni relations, and professional development. The company was founded by J. Harry Covington and Edward B. Burling on January 1, 1919 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | General Counsel | |
| Dickinson College | College/University | Director/Board Member | |
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
CereHealth Corp.
 CereHealth Corp. Medical/Nursing ServicesHealth Services CereHealth Corp. engages in the production of brain imaging software by utilizing high resolution gamma cameras. It specializes in Single-Photon Emission Computed Tomography (SPECT) & Positron Emission Tomography (PET). The company is headquartered in Littleton, CO. | Medical/Nursing Services | Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| New York University School of Law | College/University | Graduate Degree | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Foundation for Biomedical Research
 Foundation for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Foundation for Biomedical Research provides animal research and testing services. The non-profit company is based in Washington. | Miscellaneous Commercial Services | Director/Board Member | |
| Keck Graduate Institute of Applied Life Sciences | College/University | Director/Board Member | |
| Claremont College | College/University | Director/Board Member | |
| MMRGLOBAL, INC. | Information Technology Services | Director/Board Member | |
| Institute For Health Policy Analysis, Inc. | Director/Board Member | ||
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
Pendulum Therapeutics, Inc.
 Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 48 |
| Israel | 2 |
| Niederlande | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Health Services | 5 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 109 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 21 |
| Undergraduate Degree | 20 |
| Chief Executive Officer | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Ben Shapiro | 24 |
| Andrew Last | 15 |
| William V. Murray | 15 |
| Joel R. Jung | 13 |
| George F. Adam | 13 |
| Susan L. Koppy | 12 |
| William H. Longfield | 12 |
| Stacey R. Sias | 10 |
| Thomas J. White | 10 |
| Peter M. Dansky | 10 |
| Chris Yoo | 10 |
| James P. Merryweather | 9 |
| Robert Ragusa | 9 |
| Michael A. Zoccoli | 9 |
- Börse
- Insiders
- Paul D. Arata
- Unternehmensverbindungen